Keros Therapeutics, Inc.

Q4 2021 13F Holders

Symbol
KROS
CUSIP
492327101
Type
Equity
Class
COM
Num filings
105
Total reported value, excl. options
$945 M
Manager Report Date Value ($000) Shares Option Type